Seeing Is Believing
Healthcare - Sector
IMAB is currently covered by 3 analysts with an average price target of $7.67. This is a potential upside of $6.05 (92.71%) from yesterday's end of day stock price of $3.98.
I-Mab's activity chart (see below) currently has 25 price targets and 41 ratings on display. The stock rating distribution of IMAB is 100% BUY.
Analysts average stock forecasts to be materialized ratio is 27.75% with an average time for these price targets to be met of 69.69 days.
Highest price target for IMAB is $9, Lowest price target is $6, average price target is $7.67.
Most recent stock forecast was given by from BTIG on 24-Oct-2025. First documented stock forecast 11-Feb-2020.
Currently out of the existing stock ratings of IMAB, 6 are a BUY (100%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 10-Sep-2025
$9
$5.02 (126.13%)
$9
Buy Since 02-Nov-2021
$6
$2.02 (50.75%)
$5
Buy Since 28-Aug-2025
$8
$4.02 (101.01%)
Buy Since 09-Jul-2025
$7
$3.02 (75.88%)
$7
Buy Since 07-Dec-2020
$7
$3.02 (75.88%)
$7
What is IMAB (I-Mab) average time for price targets to be met?
Which analyst has the current highest performing score on IMAB (I-Mab) with a proven track record?
Which analyst has the most public recommendations on IMAB (I-Mab)?
Which analyst is the currently most bullish on IMAB (I-Mab)?
Which analyst is the currently most reserved on IMAB (I-Mab)?